Skip to content
Licensed Unlicensed Requires Authentication Published by De Gruyter (O) April 7, 2016

Oxidative radioiodination of meclofenoxate as a preclinical brain imaging agent

  • Mohamed Abd El-Motaleb Abd El-Rhman EMAIL logo , Ismail Taha Ibrahim , Sayed Mohamed Abd El-Halim and Mahmoud El-Sayed El-Tawoosy
From the journal Radiochimica Acta

Abstract

Meclofenoxate is a drug used to cause a broad improvement in brain function and mental performance. Meclofenoxate was successfully labeled with 125I via direct electrophilic substitution reaction at room temperature. Percent radiochemical yield was evaluated by paper electrophoresis and HPLC. The reaction parameters affecting the preparation process were studied in details. 125I-meclofenoxate gave maximum percent radiochemical yield of about 95 ± 1.0% with specific activity 1.9 μCi/μg meclofenoxate and its stability was up to 4 h. Biodistribution studies showed that maximum uptake of 125I-meclofenoxate in the brain of mice was 4.27 ± 0.3% injected dose (ID)/g tissue organ at 15 min post-injection. This uptake of 125I-meclofenoxate was found to be enough to image brain as it still 4.3% ID/g at 30 min post injection.

Received: 2015-11-27
Accepted: 2016-1-26
Published Online: 2016-4-7
Published in Print: 2016-7-28

©2016 Walter de Gruyter Berlin/Boston

Downloaded on 28.3.2024 from https://www.degruyter.com/document/doi/10.1515/ract-2015-2557/html
Scroll to top button